Skip to content

Modified Atkins Diet in Adolescence and Adults with Refractory Epilepsy

Efficacy, Safety and Tolerability of Modified Atkins Diet in Adolescence and Adults with Drug Resistant Epilepsy: A Randomized Controlled Trial - MAD

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/07/006048
Enrollment
160
Registered
2015-07-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G939- Disorder of brain, unspecified Health Condition 2: null- Drug Resistant Epilepsy

Interventions

Intervention1: Experimental Arm:Modified Atkins Arm Control Arm: No Dietary Intervention: Experimental Arm: Diet will be stared after 4 weeks baseline period,during which daily seizure log will be mai

Sponsors

Indian Council Of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged 10 -19yrs years and adults >19yrs- 55 years with drug resistant epilepsy (DRE). 2. Persisting, daily countable seizure (more than 2/month for 6 months). 3. Willing to come for regular follow up and able to note seizure frequency accurately. 4. Patients need to be willing to perform the induction phase of the Diet. â??DREâ??: More than 2 seizures per month for 6 months or more, on at least 3 appropriate AEDs at their maximum tolerated doses, with any one of them being a newer AED.

Exclusion criteria

Exclusion criteria: 1. 2. Surgically remediable cause for resistant epilepsy. 3. Clinical features of inborn errors of metabolism. 4. Clinical suspicion of metabolic disorder, Systemic disease-Diabetes Mellitus, Cardiovascular Disease, metabolic disease or prior Myocardial infarction. 5. Two or more the following abnormalities: a. High blood ammonia( >80mmol/L) b. High arterial lactate( >2mmol/L) c. Metabolic acidosis(Ph >7.2) d. Hypoglycemia(blood sugar 6. Refusal to give consent. 7. Patients who had tried Ketogenic diet within the past 1 year

Design outcomes

Primary

MeasureTime frame
The patients who achieve 50 percent seizure reduction in Seizure frequency in MAD at 6 months after initiation of diet therapyTimepoint: 6 months of diet initiation

Secondary

MeasureTime frame
1. Rate and characteristics of short term adverse events while on MAD. 2. Rate of withdrawal from the MAD diet during the study period and reasons for withdrawal. 3. Change in Quality of life using QOLIE-31 and QOLIE-AD-48 scale and behavior using CBCL and ABCL) in both the groups. Timepoint: F/U at 6 months after diet initiation

Countries

India

Contacts

Public ContactMala Manral

AIIMS

manjari2tripathi@gmail.com26594494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 12, 2026